A review of proton therapy – Current status and future directions

质子疗法 质子 相对生物效应 放射治疗计划 粒子疗法 航程(航空) 核医学 医学 放射治疗 物理 核物理学 辐照 材料科学 放射科 复合材料
作者
Radhe Mohan
出处
期刊:Precision radiation oncology [Wiley]
卷期号:6 (2): 164-176 被引量:322
标识
DOI:10.1002/pro6.1149
摘要

The original rationale for proton therapy was the highly conformal depth-dose distributions that protons are able to produce, compared to photons, which allow greater sparing of normal tissues and escalation of tumor doses, thus potentially improving outcomes. Additionally, recent research, which is still ongoing, has revealed previously unrecognized advantages of proton therapy. For instance, the higher relative biological effectiveness (RBE) near the end of the proton range can be exploited to increase the difference in biologically effective dose in tumors vs. normal tissues. Moreover, the smaller "dose bath", i.e., the compact nature of proton dose distributions has been found to reduce exposure of circulating lymphocytes and the immune organs at risk. There is emerging evidence that the resulting sparing of the immune system has the potential to improve outcomes. Protons, accelerated to therapeutic energies ranging from 70 to 250 MeV, are transported to the treatment room where they enter the treatment head mounted on a rotating gantry. The initially narrow beams of protons are spread laterally and longitudinally and shaped appropriately to deliver treatments. Spreading and shaping can be achieved by electro-mechanically for "passively-scattered proton therapy' (PSPT); or using magnetic scanning of thin "beamlets" of protons of a sequence of initial energies. The latter technique is used to treat patients with optimized intensity modulated proton therapy (IMPT), the most powerful proton therapy modality, which is rapidly supplanting PSPT. Treatment planning and plan evaluation for proton therapy require different techniques compared to photon therapy due, in part, to the greater vulnerability of protons to uncertainties, especially those introduced by inter- and intra-fractional variations in anatomy. In addition to anatomic variations, other sources of uncertainty in the treatments delivered include the approximations and assumptions of models used for computing dose distributions and the current practice of proton therapy of assuming the RBE to have a constant value of 1.1. In reality, the RBE is variable and a complex function of proton energy, dose per fraction, tissue and cell type, end point, etc. Despite the high theoretical potential of proton therapy, the clinical evidence supporting its broad use has so far been mixed. The uncertainties and approximations mentioned above, and the technological limitations of proton therapy may have diminished its true clinical potential. It is generally acknowledged that proton therapy is safe, effective and recommended for many types of pediatric cancers, ocular melanomas, chordomas and chondrosarcomas. Promising results have been and continue to be reported for many other types of cancers as well; however, they are based on small studies. At the same time, there have been reports of unforeseen toxicities. Furthermore, because of the high cost of establishing and operating proton therapy centers, questions are often raised about the value of proton therapy. The general consensus is that there is a need for continued improvement in the state of the art of proton therapy. There is also a need to conduct randomized trials and/or collect outcomes data in multi-institutional registries to generate high level evidence of the advantages of protons. Fortuitously, such efforts are taking currently place. Ongoing research is aimed at better understanding the biological and immunomodulatory effects of proton therapy and the consequences of the physical uncertainties on proton therapy and reducing them through image-guidance and adaptive radiotherapy. Since residual uncertainties will remain despite our best efforts, in order to increase the resilience of dose distributions in the face of uncertainties and improve our confidence in dose distributions seen on treatment plans, robust optimization techniques are being developed and implemented and continue to be perfected. Such research and continuing technological advancements in planning and delivery methods are likely to help demonstrate the superiority of protons.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
丘比特的应助被叫你吃布丁采纳,获得10
刚刚
wanci的应助被winnie采纳,获得10
刚刚
刚刚
龙弟弟发布了新的文献求助10
1秒前
KK发布了新的文献求助10
1秒前
自由的迎南完成签到,获得积分10
1秒前
1秒前
achilles完成签到,获得积分10
1秒前
朴实的母鸡完成签到,获得积分10
1秒前
背后的小白菜完成签到,获得积分10
1秒前
四季西瓜完成签到,获得积分10
2秒前
2秒前
ICE发布了新的文献求助10
2秒前
风清扬的应助被苗子采纳,获得10
3秒前
wei完成签到,获得积分10
3秒前
深情安青的应助被heady采纳,获得10
3秒前
3秒前
3秒前
Orange的应助被xuehufdgierviehc采纳,获得10
3秒前
科研小白完成签到,获得积分10
4秒前
务实寄松发布了新的文献求助10
4秒前
宝宝完成签到,获得积分10
5秒前
负责雨安完成签到 ,获得积分10
5秒前
桐桐的应助被yan采纳,获得10
5秒前
微笑梦易完成签到,获得积分10
5秒前
5秒前
5秒前
6秒前
阿萨德完成签到,获得积分10
6秒前
7秒前
7秒前
风趣的雪柳完成签到,获得积分10
7秒前
7秒前
哦吼吼吼吼完成签到 ,获得积分10
7秒前
gm发布了新的文献求助10
8秒前
小小完成签到,获得积分10
8秒前
爆米花的应助被raoarao采纳,获得40
8秒前
情怀的应助被给里奥采纳,获得10
8秒前
哈哈哈哈完成签到,获得积分10
8秒前
标致青雪发布了新的文献求助10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181014
求助须知:如何正确求助?哪些是违规求助? 9571039
关于积分的说明 21816042
捐赠科研通 7777369
什么是DOI,文献DOI怎么找? 3433378
关于科研通互助平台的介绍 2557621
邀请新用户注册赠送积分活动 2479385